Reyes-García Rebeca, Moreno-Pérez Óscar, Tejera-Pérez Cristina, Fernández-García Diego, Bellido-Castañeda Virginia, de la Torre Casares Martín López, Rozas-Moreno Pedro, Fernández-García José Carlos, Marco Martínez Amparo, Escalada-San Martín Javier, Gargallo-Fernández Manuel, Botana-López Manuel, López-Fernández Judith, González-Clemente José Miguel, Jódar-Gimeno Esteban, Mezquita-Raya Pedro
Unidad de Endocrinología y Nutrición, Hospital Universitario Torrecárdenas, Servicio de Endocrinología, Clínica San Pedro, Almería, España; Servicio de Endocrinología, Clínica San Pedro, Almería, España.
Sección de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Universidad Miguel Hernández, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-FISABIO), Alicante, España.
Endocrinol Diabetes Nutr (Engl Ed). 2019 Aug-Sep;66(7):443-458. doi: 10.1016/j.endinu.2018.10.010. Epub 2019 Feb 28.
Treatment of type 2 diabetes mellitus (T2DM) is complex and is intended to decrease morbidity and mortality. Management should therefore include adequate diabetes education, lifestyle changes, drug treatment to achieve early blood glucose control and reduction of cardiovascular (CV) risk factors, early detection and treatment of complications, and assessment of associated comorbidities. The objective was to prepare a document including all aspects required for a comprehensive approach to T2DM.
Members of the Diabetes Mellitus Working Group of the Spanish Society of Endocrinology.
The available evidence regarding each aspect of diabetes management (blood glucose control goals, diet and exercise, drug treatment, risk factor management and control, detection of complications, and management of frail patients) was reviewed. Recommendations were formulated based on the grades of evidence stated in the 2018 Standards of Medical Care in Diabetes. Recommendations were discussed and agreed by the working group members.
This document is intended to provide evidence-based practical recommendations for comprehensive management of T2DM by clinical endocrinologists.
2型糖尿病（T2DM）的治疗较为复杂，旨在降低发病率和死亡率。因此，管理应包括充分的糖尿病教育、生活方式改变、药物治疗以实现早期血糖控制并降低心血管（CV）危险因素、并发症的早期检测与治疗以及相关合并症的评估。目标是编写一份包含T2DM综合治疗所需各方面内容的文件。
西班牙内分泌学会糖尿病工作组成员。
回顾了有关糖尿病管理各方面（血糖控制目标、饮食与运动、药物治疗、危险因素管理与控制、并发症检测以及体弱患者管理）的现有证据。根据《2018年糖尿病医疗护理标准》中所述的证据等级制定了建议。工作组成员对建议进行了讨论并达成一致。
本文件旨在为临床内分泌科医生对T2DM进行综合管理提供基于证据的实用建议。
